1. Home
  2. HROW vs UFPT Comparison

HROW vs UFPT Comparison

Compare HROW & UFPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HROW
  • UFPT
  • Stock Information
  • Founded
  • HROW 1998
  • UFPT 1963
  • Country
  • HROW United States
  • UFPT United States
  • Employees
  • HROW N/A
  • UFPT N/A
  • Industry
  • HROW Biotechnology: Pharmaceutical Preparations
  • UFPT Medical/Dental Instruments
  • Sector
  • HROW Health Care
  • UFPT Health Care
  • Exchange
  • HROW Nasdaq
  • UFPT Nasdaq
  • Market Cap
  • HROW 1.4B
  • UFPT 1.6B
  • IPO Year
  • HROW N/A
  • UFPT 1993
  • Fundamental
  • Price
  • HROW $33.71
  • UFPT $224.87
  • Analyst Decision
  • HROW Strong Buy
  • UFPT Buy
  • Analyst Count
  • HROW 7
  • UFPT 2
  • Target Price
  • HROW $68.50
  • UFPT $289.00
  • AVG Volume (30 Days)
  • HROW 558.8K
  • UFPT 132.1K
  • Earning Date
  • HROW 11-10-2025
  • UFPT 11-03-2025
  • Dividend Yield
  • HROW N/A
  • UFPT N/A
  • EPS Growth
  • HROW N/A
  • UFPT 23.11
  • EPS
  • HROW N/A
  • UFPT 8.61
  • Revenue
  • HROW $227,661,000.00
  • UFPT $597,952,000.00
  • Revenue This Year
  • HROW $43.92
  • UFPT $21.64
  • Revenue Next Year
  • HROW $41.22
  • UFPT $6.29
  • P/E Ratio
  • HROW N/A
  • UFPT $26.06
  • Revenue Growth
  • HROW 47.69
  • UFPT 29.47
  • 52 Week Low
  • HROW $20.85
  • UFPT $178.26
  • 52 Week High
  • HROW $54.19
  • UFPT $354.22
  • Technical
  • Relative Strength Index (RSI)
  • HROW 31.53
  • UFPT 62.56
  • Support Level
  • HROW $36.20
  • UFPT $216.91
  • Resistance Level
  • HROW $38.52
  • UFPT $263.40
  • Average True Range (ATR)
  • HROW 1.65
  • UFPT 12.44
  • MACD
  • HROW -0.43
  • UFPT 3.99
  • Stochastic Oscillator
  • HROW 10.74
  • UFPT 52.90

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About UFPT UFP Technologies Inc.

UFP Technologies Inc is a designer and custom manufacturer of components, subassemblies, products, and packaging utilizing specialized foams, films, and plastics for the medical market. The company manufactures its products by converting raw materials using laminating, molding, radio frequency and impulse welding, and fabricating manufacturing techniques. It is an important link in the medical device supply chain and a valued outsource partner to many of the top medical device manufacturers in the world. The company's single-use and single-patient devices and components are used in a wide range of medical devices, disposable wound care products, infection prevention, minimally invasive surgery, wearables, orthopedic soft goods, and orthopedic implant packaging.

Share on Social Networks: